Novo to Cut Ozempic and Wegovy Prices Amid Intense Competition
The weight-loss drugs that kicked off America’s GLP-1 craze are about to get a lot less expensive, though only certain customers will notice the savings. Novo Nordisk said it will slash list prices of the blockbuster diabetes and weight-loss medications Ozempic, Rybelsus, and Wegovy to $675 for a one-month supply effective Jan. 1, 2027. All … Read more
